BSECompany Update28 Jul 2026 · 28 Jul 2026, 05:29 pm

The Exchange has sought clarification from Dr Reddys Laboratories Ltd with reference to the media report appearing on https://www.business-standard.com dated July 28, 2026, (Link:https://www.business-standard.com/companies/news/dr-reddys-first-in-class-gonorrhoea-drug-gets-thailand-approval-after-us-nod-126072700632_1.html) ....

Dr Reddys Laboratories Ltd · 500124

✦ AI SummaryRegulatory

Dr Reddys Laboratories Ltd has been asked by the exchange to clarify a media report regarding the company's first-in-class gonorrhoea drug receiving approval in Thailand after receiving US nod.

Analysis Scores

Earnings Impact2/10

Growth Catalyst6/10

Governance Concern1/10

Regulatory Risk8/10

Balance Sheet Risk1/10

Liquidity Impact5/10

Market Sentiment4/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

Full Announcement

Dr Reddys Laboratories Ltd - 500124 - Clarification sought from Dr Reddys Laboratories Ltd